AVCAIDE: The Experiences of Family Caregivers of Stroke Patients: A Cross-sectional Study of a French Cohort

Sponsor
Groupe Hospitalier Paris Saint Joseph (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04741451
Collaborator
(none)
16
2
20
8
0.4

Study Details

Study Description

Brief Summary

Stroke is the most common cause of non-traumatic disability in adults and ranks second among causes of dementia and third among causes of death. In France, stroke affects around 140,000 patients each year and entails enormous economic costs. Given the average age of onset of stroke, its prevalence is expected to increase with increasing life expectancy and the advancing age of the population.

Clinically, depending on the region of the brain affected, stroke results in a sudden and abrupt onset of sensorimotor, cognitive, emotional and / or behavioral manifestations, associated with variable recovery from patient to patient. Stroke has psychological, social and family consequences. Indeed, its occurrence could affect patients on a physical and psychological level (direct physical and cognitive sequelae of stroke, decrease or even absence of autonomy and dependence of the entourage, associated psychological changes) and generate repercussions on the dynamics. family or that of the couple (ie, changes in activities, redistribution of tasks, changes or even inversion of roles, alteration of the intimate sphere), as well as professional and social life. This could hamper the quality of life of patients and their loved ones and cause collateral damage to their social or family environment.

After discharge from the hospital, the patient's relatives will play a major role in taking charge of home care (e.g. household activities and personal care around hygiene, food, mobility and administration. treatments) as well as in the community (eg purchase of clothes or food, accompaniment to medical visits), although these helpers do not have the professional knowledge and skills in care. Despite the positive effects that caregivers can have in connection with the care they provide (ie, feeling of accomplishment and usefulness, development of a sense linked to this helping role, better self-esteem, improvement of personal skills), their continued investment in their sick relatives could deprive them of their resources, making them "hidden or invisible patients / victims". In addition, the gap between caregiver capacities to provide care and the health needs of patients could result in caregiver burden (i.e., caregiving burden). Caregivers of stroke patients experience an impaired quality of life, neglect of their own health, reduced work and leisure activities, as well as psychological suffering involving feelings of abandonment, loneliness and helplessness. uncertainty. In the context of a stroke, caregivers may be overwhelmed by the emotions of their ill loved ones as well as their own emotions. Emotional regulation is essential in such a context rich in emotional experience; it is the set of strategies that enables individuals to influence the emotions they feel, when they appear, and how they experience and express them.

Reviews of the literature have highlighted the lack of studies addressing the burden on caregivers and the need for research to identify those at risk and implement appropriate interventions.

No French study has specifically addressed the notion of the burden of caregivers of stroke patients, their coping strategies, their experiences or emotional regulations. This type of study would however constitute a step towards the design and implementation of personalized care (eg: psychotherapies), by strengthening effective / adaptive strategies and modifying those which are less effective / poorly adaptive. This could improve the well-being of caregivers and their sick relatives, and direct health policies to reduce the economic impact of this aid.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    16 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Experiences of Family Caregivers of Stroke Patients: A Cross-sectional Study of a French Cohort
    Actual Study Start Date :
    Jan 28, 2021
    Actual Primary Completion Date :
    May 31, 2021
    Anticipated Study Completion Date :
    Sep 30, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Charge of assistance to family caregivers [Month 3]

      This outcome corresponds to the support for caregivers using the Brief Burden Interview.

    2. Charge of assistance to family caregivers [Month 3]

      This outcome corresponds to the support for caregivers using Caregiver Reaction Assessment.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    For patients:
    • Patient whose age is ≥ 18 years

    • Patient having had a stroke

    • Patient hospitalized in UNV

    • Patient able to understand the information and no objection form

    • Patient who did not need help before the onset of stroke (retrospective evaluation with a score <2 on the Rankin scale

    • Patient having spent at least 3 months at home (directly after hospitalization in UNV or after undergoing rehabilitation)

    • Patient with sequelae upon discharge from hospital (score ≥ 2 on the Rankin scale)

    • French-speaking patient

    For caregivers:
    • Caregiver whose age is ≥ 18 years

    • Caregiver of the patient with stroke

    • Being a family caregiver according to Article L. 113-1 of the Social Action and Families Code for at least 3 months and at most 12 months

    Exclusion Criteria:
    For patients:
    • Patient who suffered from a transient ischemic attack

    • Patient who has had two or more strokes

    • Patient with a disability before the onset of stroke (score ≥2 on the Rankin scale)

    • Patient under guardianship or curatorship

    • Patient deprived of liberty

    • Patient under legal protection

    • Patient objecting to the use of their data for this research

    For caregivers:
    • Helping another person at the same time.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Groupe Hospitalier Paris Saint Joseph Paris Groupe Hospitalier Paris Saint-Joseph France 75014
    2 Institut de Psychologie, Université de Paris Boulogne France 92774

    Sponsors and Collaborators

    • Groupe Hospitalier Paris Saint Joseph

    Investigators

    • Principal Investigator: Mathieu Zuber, MD, Groupe Hospitalier Paris Saint Joseph

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Groupe Hospitalier Paris Saint Joseph
    ClinicalTrials.gov Identifier:
    NCT04741451
    Other Study ID Numbers:
    • AVCAIDE
    First Posted:
    Feb 5, 2021
    Last Update Posted:
    Jun 30, 2022
    Last Verified:
    Jun 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 30, 2022